COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 645: Articles 6441-6450  | Next

Are primary care virtual visits associated with higher emergency department use? A cross-sectional analysis from Ontario, Canada
Kiran, T., Green, M. E., Strauss, R., Wu, C. F., Daneshvarfard, M., Kopp, A., Lapointe-Shaw, L., Latifovic, L., Frymire, E., Glazier, R. H.
10.1101/2022.09.08.22278709 — Posted: 2022-09-09
SARS-CoV-2 seroprevalence on the north coast of Peru: A cross-sectional study after the first wave
Moyano, L. M., Toledo, A. K., Chirinos, J., Vilchez Barreto, P. M. Q., Cavalcanti, S., Gamboa, R., Ypanaque, J., Meza, M., Noriega, S., Herrera, V., Bazan, E., Requena, A., Silva, H., Burgos, H., Leon-Jimenez, F., Group of Neuroepidemiology and Science of Life of Peru
10.1101/2022.09.07.22279669 — Posted: 2022-09-09
Genomic epidemiology of SARS-CoV-2 infections in The Gambia, March 2020 to Jan 2022
Kanteh, A., Jallow, H. S., Manneh, J., Sanyang, B., Kujabi, M. A., Ndure, S. L., Jarju, S., Sey, A. P., Damilare, D. K., Bah, Y., Sambou, S., Jarju, G., Manjang, B., Jagne, A., Bittaye, S. O., Bittaye, M., Forrest, K., Tiruneh, D. A., Samateh, A. L., Jagne, S., Hue, S., Mohammed, N., Amambua-Ngwa, A., Kampmann, B., D'Alessandro, U., de Silva, T. I., Roca, A., Sesay, A. K.
10.1101/2022.09.07.22278739 — Posted: 2022-09-09
Associations of habitual glucosamine use with SARS-CoV-2 infection and hospital admission and death with COVID-19: Evidence from a large population based cohort study
Meng, M., Wu, Y., Zeng, R., Luo, D., Jiang, R., Wu, H., Zhuo, Z., Yang, Q., Li, J., Leung, F., Chen, Q., Sha, W., Chen, H.
10.1101/2022.09.05.22279621 — Posted: 2022-09-09
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
Kanokudom, S., Chansaenroj, J., Suntronwong, N., Assawakosri, S., Yorsaeng, R., Nilyanimit, P., Aeemjinda, R., Khanarat, N., Vichaiwattana, P., Klinfueng, S., Thongmee, T., Katanyutanon, A., Thanasopon, W., Arayapong, J., Withaksabut, W., Srimuan, D., Thatsanatorn, T., Sudhinaraset, N., Wanlapakorn, N., Honsawek, S., Poovorawan, Y.
10.1101/2022.09.07.22279684 — Posted: 2022-09-09
An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India
Karyakarte, R. P., Das, R., Taji, N., Yanamandra, S., Shende, S., Joshi, S., Karekar, B., Bawale, R., Tiwari, R., Jadhav, M., Sakalkar, S., Chaudhari, G., Rane, S., Agarasen, J., Pillai, P., Dudhate, S., Chandankhede, P., Labhshetwar, R., Gadiyal, Y., Rajmane, M., Mukade, S., Kulkarni, P.
10.1101/2022.09.07.22279665 — Posted: 2022-09-09
Time trends between vaccination coverage and voting patterns before and during the COVID-19 pandemic: analysis of COVID-19 and flu surveys in the United States
Ronn, M. M., Menzies, N. A., Salomon, J. A.
10.1101/2022.09.05.22279620 — Posted: 2022-09-09
Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19: Challenges of Emerging Variants
Sharma, R., Zang, W., Tabartehfarahani, A., Lam, A., Huang, X., Sivakumar, A. D., Thota, C., Yang, S., Dickson, R. P., Sjoding, M. W., Bisco, E., Mahmood, C. C., Diaz, K. M., Sautter, N., Ansari, S., Ward, K. R., Fan, X.
10.1101/2022.09.06.22279649 — Posted: 2022-09-09
Head-to head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UK
Cubas Atienzar, A. I., Byrne, R. L., Aljayyoussi, G., Kontogianni, K., Bengey, D., Clerkin, K., McIntyre, M., Wardale, J., Willams, C. T., Body, R., Escadafal, C., Adams, E. R.
10.1101/2022.09.06.22279637 — Posted: 2022-09-09
The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths in South Africa
Silal, S. P., Pulliam, J., Meyer-Rath, G., Jamieson, L., Nichols, B., Norman, J., Hounsell, R., Mayet, S., Kagoro, F., Moultrie, H.
10.1101/2022.09.05.22279174 — Posted: 2022-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).